Health Care Providers
In a severe hypoglycemia emergency
Ready for rescue
The first and only glucagon with nasal administration
BAQSIMI™ is indicated for the treatment of severe hypoglycemic reactions which may occur in the management of insulin treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrates.
Choose a patient type below
![](https://www.baqsimi.ca/wp-content/uploads/2024/03/pediatric-patient-1024x576.jpg)
![](https://www.baqsimi.ca/wp-content/uploads/2024/03/adult-patient-1024x576.jpg)